Aravind Arepally, MD, FSIR (he/him/his)

Chief Medical Officer
ABK Biomedical Inc., United States

Disclosure information not submitted.

Presentation(s):

• 75 - A Clinical Comparison Between Nuclear Medicine and CT-based Post-treatment Dosimetry Following 90Y-radioembolization with Multi-modality Imageable Eye90 Microspheres

  Sunday, April 12, 2026
  3:36 PM - 3:45 PM ET

• 313 - Histopathological and Quantitative Micro-CT Analysis of Microsphere Clustering in an OncoPig Model with Imageable Eye90

  Wednesday, April 15, 2026
  12:27 PM - 12:36 PM ET